trending Market Intelligence /marketintelligence/en/news-insights/trending/WycWRFvquSGvf0bwSLQ2Xw2 content esgSubNav
In This List

Aclaris plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aclaris plans common stock offering

Aclaris Therapeutics Inc. plans to sell up to $75 million of its common stock in an underwritten public offering.

The company will grant underwriters an option to buy up to an additional $11.3 million of common stock.

Jefferies LLC and Leerink Partners LLC are acting as joint book-running managers for the offering. William Blair & Co. LLC, Guggenheim Securities LLC, and JMP Securities LLC are acting as co-managers for the offering.